期刊文献+

^(32)P-磷酸铬-聚L-乳酸缓释粒子对荷H22肝癌小鼠的抑瘤作用及对Caspase-3和Caspase-8表达的影响 被引量:1

Effects of ^(32)P-chromic-poly L-lactide brachytherapy on H22 liver cancer-induced xenograft and expressions of Caspase-3 and Caspase-8 in mice
原文传递
导出
摘要 目的观察32P-磷酸铬-聚L-乳酸(32 P-CP-PLLA)粒子瘤体植入后对荷H22肝癌KM小鼠移植瘤的抑瘤效果和对Caspase-3和Caspase-8蛋白表达的影响。方法建立荷H22肝癌KM模型小鼠45只后均分为粒子组(瘤内植入活度为7.4MBq的32P-CP-PLLA粒子1枚)、胶体组(瘤内注射活度为7.4MBq的32P-CP胶体)和对照组三组。分别于第1、6、12、24小时每组各处死3只小鼠,用分光光度法检测瘤体Caspase-3和Caspase-8的表达。每组3只小鼠每2天测量肿瘤体积,第14天测量肿瘤质量,计算抑瘤率。结果治疗第14天,粒子组抑瘤率高于胶体组[(62.28±2.36)%vs.(50.28±3.22)%](P<0.05)。与对照组比较,胶体组和粒子组各时间点的Caspase-3和Caspase-8的表达增高(P<0.05)。结论 32P-CP-PLLA粒子对荷H22小鼠移植瘤具有抑瘤和诱导细胞凋亡作用,适合于肝癌实体瘤的近距离治疗。 Objective To investigate the effects of 32 P-chromic-poly L-lactide(s2 P-CP-PLLA) brachytherapy on H22 liver cancer cell-induced xenograft and the expressions of Caspase-3 and Caspase-8 in mice. Methods The xenograft models were established by transplantation of H22 tumor cells in 45 mice, which were equally assigned into three groups of A(32 P-CP-PLLA), B(3z P-chromic phosphate colloid) and C(model control). Three mice from each group were killed at 1,6, 12 and 24h, respectively, for detecting the expressions of Caspase-3 and Caspase-8 in tumor by spectrophotometry. The volume of xenograft in 3 mice from each group was measured every other day and tumor mass was detected on the 14th day, by which the inhibition rate was calculated. Results The inhibition rate on the 14th day was higher in group A than that in group BE(62.28±2.36)% vs. (50. 28±3.22)%](P〈0. 05). The expressions of Caspase-3 and Caspase-8 were higher in groups of A and B than those in group C(P〈0. 05). Conclusion 3z P-CP-PLLA is able to supress the growth and induce tumor cell apoptosis, which as brachytherapy is suitable to treat hepatocelluar carcinoma soild tumors.
出处 《江苏医药》 CAS 北大核心 2014年第14期1631-1633,共3页 Jiangsu Medical Journal
基金 国家自然科学基金(81071185)
关键词 32p 聚L乳酸 肝细胞癌 近距离放疗 32 Phosphate Poly-L-Lactide Hepatocelluar carcinoma Brachytherapy
  • 相关文献

参考文献2

二级参考文献9

共引文献12

同被引文献9

  • 1Firusian N,Dempke W.An early phaseⅡstudy of intratumoral P-32chromic phosphate injection therapy for patients with refractory solid tumors and solitary metastases[J].Cancer,1999,85(4):980-987.
  • 2Azhdarinia A,Yang DJ,Yu DF,et al.Regional radiochemotherapy using in situ hydrogel[J].Pharma Res,2005,22(5):776-783.
  • 3Zubillaga MB,Boccio JR,Niconili JO,et al.Use of colloids of chromic[32P]phosphate in treatment of solid tumors[J].Nucl Med Biol,1996,23(7):907-910.
  • 4Zhang K,Loonq SL,Yu SW,et al.Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic carcinoma xenografts in nude mice[J].Clin Cancer Res,2005,11(20):7532-7537.
  • 5Goh AS,Chuang AY,Lo RH,et al.A novel approach to brachytherapy in hepatocellular carcinoma using aphosphorous32(32P)brachytherapy delivery device--a first-in-man study[J].Int J Radiat Oncol Biol Phys,2007,67(3):786-792.
  • 6Cheng L,Jones TD,Lin H,et al.Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma[J].J Urol,2005,174(6):2181-2185.
  • 7邵国强,王自正,刘璐,王峰,李少华,张乐乐,黄培林,杨敏,祁本忠.^32P-磷酸铬-聚L-乳酸缓释粒子的制备及其放射性释出和生物分布[J].中华核医学杂志,2009,29(3):189-193. 被引量:13
  • 8郭新春,邵国强,黄岩,王自正,李少华,刘璐,杨敏,王峰.^(32)P放射性活度对^(32)P-磷酸铬-聚L-乳酸缓释粒子降解特性影响的初步研究[J].南京医科大学学报(自然科学版),2011,31(11):1593-1596. 被引量:1
  • 9孙柳静,邵国强,王自正,朱喜山,徐龙宝,赵骏.^32P-磷酸铬-聚L-乳酸粒子植入对荷人前列腺癌裸鼠移植瘤的抑瘤效应和药物分布实验[J].中华核医学与分子影像杂志,2012,32(6):457-462. 被引量:2

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部